19.04.2018 06:18:14
|
P&G Buys Consumer Health Unit Of Merck KGaA, Darmstadt, Germany For EUR 3.4 Bln
(RTTNews) - The Procter & Gamble Company (PG) announced that it has signed an agreement to acquire the Consumer Health business of Merck KGaA, Darmstadt, Germany, for purchase price of about 3.4 billion euros. P&G expects to close this deal during the 2018/19 fiscal year.
The Consumer Health business of Merck KGaA, Darmstadt, Germany, is active across 44 countries and includes more than 900 products.
P&G specified that this acquisition replaces and improves upon the highly successful PGT Healthcare joint venture P&G had with Teva Pharmaceutical Industries (TEVA), which will be terminated July 1, 2018.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Nachrichten
Analysen zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Procter & Gamble Co. | 163,32 | 2,19% | |
Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 21,40 | 0,00% |